Skip to main content
OpenTrials

Clinical trial condition

Raynaud Disease

Explore clinical trials studying Raynaud Disease. Study availability and eligibility vary by location and protocol.

56 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Raynaud Disease trial results

Recruiting

Open Label Treprostinil Raynaud's Study

NCT07112183

Conditions
Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +12 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

NCT06675344

Conditions
Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +14 more
Locations
  • DelRicht Research Center New Orleans, Louisiana, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Pittsburgh and UPMC Scleroderma Center Pittsburgh, Pennsylvania, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Recruiting

Multi-modal Quantitative Imaging of the Skin

NCT06989216

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +36 more
Locations
  • Atrium Health Care Centre Stockholm, Sweden
  • Neko Health Centre Regeringsgatan Stockholm, Sweden
  • Neko Health Centre Sibyllegatan Stockholm, Sweden
View Trial Details
Completed

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)

NCT04040322

Conditions
Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +10 more
Locations
  • Arizona Arthritis & Rheumatology Research, PLLC Phoenix, Arizona, United States
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • University of Arizona - Arthritis Research Center Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 30 locations
View Trial Details
Completed

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

NCT03867097

Conditions
Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +10 more
Locations
  • Arizona Arthritis & Rheumatology Research, PLLC Phoenix, Arizona, United States
  • Pacific Arthritis Care Center of Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 16 locations
View Trial Details

Related conditions